The ability of the adult pancreas to generate new insulin (␤) cells has been controversial because of difficulties in unequivocally identifying the precursor population. We recently determined that ␤ cells were generated during development from precursors that expressed the homeodomain-containing transcription factor pancreas duodenum homeobox gene-1 (PDX-1). To investigate whether PDX-1 ϩ stem cells are present in adult pancreas, we examined two animal models of diabetes. One model was produced by injecting adult mice with streptozotocin (SZ), a toxin that produces hyperglycemia due to rapid and massive ␤ cell death. 
I
T IS GENERALLY believed that pancreatic exocrine and endocrine cells develop from precursor cells present in the pancreatic duct (1) . Embryonic endocrine cells aggregate and form the islets of Langerhans, which, in mice, achieve a typical adult configuration after birth. Insulin (IN)-containing ␤ cells form the core of the mature islets, whereas the periphery contains lower numbers of the other endocrine cell types: the ␣, Ѩ, and PP cells, which synthesize glucagon (GLU), somatostatin (SOM) and pancreatic polypeptide (PP) respectively.
To elucidate the cell lineage relationships of pancreatic islet cells, the biochemical properties of the progenitor cells have been examined by us (2, 3) and others (4 -6) . The first molecular marker expressed by islet stem cells during development is a homeodomain protein, pancreas duodenum homeobox gene-1 (PDX-1). PDX-1 plays a key transcriptional role during the development of both the endocrine and exocrine pancreas as demonstrated by targeted mutagenesis experiments in mice (7, 8) . It has been found that PDX-1, previously termed STF-1 (9), IDX-1(10), or IPF-1 (11) , is transiently expressed by precursor cells present in the pancreatic duct and by each of the four endocrine cell types when they first differentiate (3) . Pancreatic PDX-1 expression becomes progressively restricted during development such that it is almost exclusively localized to ␤ cells in adults (12, 13) , where it is believed to play a role in the regulation of IN gene transcription (11) (12) (13) (14) . In addition to ␤ cells, a small subset of the ␣, Ѩ, and PP cells express PDX-1 (12, 13) There is considerable evidence suggesting that the differentiation of PDX-1 ϩ progenitor cells into pancreatic islet cells occurs by a multistep process, involving successive changes in the antigenic profile of the stem cells. PDX-1 cells coexpressing IN and GLU appear at e-9.5 in the pancreatic buds of mice before full morphogenesis of the pancreas (3). Coexpression of IN, GLU, and PDX-1 by islet cells decreases during gestation, such that a significant number of cells either were GLU ϩ or IN ϩ PDX-1 ϩ by e-14.5 (3) . SOM ϩ PDX-1 ϩ and PP ϩ PDX-1 ϩ cells are first seen at e-14.5 and postnatal day 1 (P-1), respectively (3) . At these stages a subset of SOM ϩ and PP ϩ cells coexpress IN (2) . These observations, together with similar findings in other systems (4, 15, 16) , suggest that the four principal islet cell types arise from common multipotential precursors that coexpress PDX-1, GLU, and IN (3) .
The increase in ␤ cell number during embryonic development and early postnatal life is presumed to occur by continued differentiation of new islet precursors cells from the pancreatic duct and by proliferation of differentiated IN ϩ cells (1, (17) (18) (19) (20) (21) . In adults, new IN ϩ cells arise mostly from division of existing ␤ cells (reviewed in Ref. 19) .
Neogenesis, the differentiation of IN cells from stem-like cells present in the pancreas, has been reported to occur in several animal models, including after ␤ cell destruction with toxins in neonatal rats (22) , after cellophane wrapping of the pancreas in adults (23) , after partial pancreatectomy, (24) , and in some transgenic mouse models of autoimmune dia-betes (25, 26) . However, in all these studies, attempts to demonstrate how the new ␤ cells were generated were hampered by the inability to unambiguously identify the precursor cells. The recent identification of GLU ϩ /IN ϩ /PDX-1 ϩ cells as a likely embryonic islet stem cells (3) prompted us to ascertain whether similar cells were found in adult pancreas. High circulating blood sugar has been postulated to induce the differentiation of ␤ stem cells into IN ϩ cells (19) . As a consequence, we examined pancreatic tissues of diabetic mice to determine whether islets contained newly differentiated ␤ cells. We reasoned that PDX-1 ϩ ␤ precursor cells in adults might be located in the pancreatic duct, as in embryos. Alternatively, these ␤ precursor cells may be scattered in the exocrine tissue or clustered in islets. Furthermore, we hypothesized that these cells could be induced to differentiate by mechanisms unleashed by islet injury. To address this hypothesis, we analyzed ␤ cell neogenesis in pancreas in two different animal model systems. The first consisted of mice injected with SZ, a specific ␤ cell toxin (17, 27 ; reviewed in Ref. 28) . SZ consists of 1-methyl-1 nitrosourea attached to the C-2 of d-glucose. It is believed that the basis of the selective effect of SZ on ␤ cells is its glucose moiety, which reacts with specific glucose sensing mechanisms (28, 29) . A widely accepted view is that it acts within ␤ cells to deplete nicotinamide adenine dinucleotide (NAD), producing long-lasting impairment and death of ␤ cells (28, 30) . To determine whether the appearance of new ␤ cells was correlated with the degree of islet injury, pancreatic tissues of mice injected either with 200 mg/kg SZ (200 SZ mice) or 100 mg/kg SZ (100 SZ mice) were compared. While the higher dose of SZ eliminated almost all ␤ cells within a few hours after exposure of the drug, the lower dose caused a partial reduction of the ␤ cell mass (28, 31) . The second model examined was the NOD mouse strain, in which mature ␤ cells are lost through an autoimmune destruction (reviewed in Ref. 28) .
We found few PDX-1 ϩ ␤ cells in the pancreatic duct in all of these animal models of diabetes. Importantly, injection of 200 mg/kg SZ with the resulting elimination of most of the existing ␤ cells induced the differentiation of significant numbers of SOM ϩ /PDX-1 ϩ cells, a transitional cell type in the endocrine cell lineage (3), in all pancreatic islets. The appearance of these transitional cells was followed by the differentiation of a large number of SOM ϩ cells also expressing IN. SOM ϩ /PDX-1 ϩ cells also differentiated in islets of 100 SZ and NOD mice. We conclude that mature islets contain a PDX-1 ϩ ␤ stem cell population that can be induced to differentiate into IN ϩ cells following islet injury.
Materials and Methods

Animals and tissue processing
Six-week-old male CD-1 mice were purchased from Charles River (Wilmington, MA). Mice were injected ip with SZ (Upjohn Co., Kalamazoo, MI; USB/Amersham, Arlington Heights, IL) in 0.1 m citrate buffer, pH 4.5, after a 12-h overnight fast. The drug was administered immediately after preparation of the solution. Mice injected with SZ at 200 mg/kg (200 SZ mice) after an overnight fast became severely hyperglycemic (blood glucose levels over 400 mg/dl) 24 h later. Animals that received 100 mg/kg SZ (100SZ mice) also became hyperglycemic, but the increase in blood glucose levels occurred at a slower rate, reaching very high levels (over 400 mg/dl) 2-3 days after the treatment. Controls were injected with the equivalent volume of citrate buffer. Blood for glucose determination was collected by snipping the tail in the fed state. Blood glucose was measured with Tracer II Blood Glucose monitor (Boehringer Mannheim Corp., Indianapolis, IN). Animals with a plasma glucose of 400 mg/dl or higher were used.
One-month-old female NOD mutant and control (ICR) mice were purchased from Taconic Farms (Germantown, NY) and were kept for the required amount of time in the animal colony of SUNY.
Mice were perfused through the heart with Zamboni's fixative (85 ml 2% paraformaldehyde in 0.1 m phosphate buffer, pH 7.4, plus 15 ml saturated picric acid) and postfixed for several hours in the same fixative. For semithin epon sections, tissues were stored overnight in 7% sucrose in phosphate buffer and dehydrated through a graded series of ethanols to propylene oxide. After dehydration, the tissues were transferred to a mixture of propylene oxide: epon (1:1) for 2 h, then placed in Epon 812-filled capsules at 37 C overnight, followed by a 24-h incubation at 45 C, and an overnight incubation at 60 C as previously described (32) . For cryostat sections, the fixed tissues were infiltrated overnight in 30% sucrose, mounted in embedding matrix (Lipshaw Co., Pittsburgh, PA), and 15-20 m cryostat sections were collected onto gelatin-coated slides.
Source of antibodies and purified peptides
Primary antiserum. Guinea pig antibodies to bovine IN were purchased from Linco Research Inc. (Eureka, MO). Rabbit antiserum to human glucagon was purchased from Calbiochem (San Diego, CA). Rabbit antisera to human PP and to somatostatin were supplied by Peninsula Labs (Belmont, CA). Affinity purified antiserum to the N-terminal domain of PDX-1 was raised against the first 75 amino acids of PDX-1 as a GST/XIH box 8 fusion protein (13, 33) .
Secondary antibodies. Biotinylated goat antirabbit IgG and avidin-labeled peroxidase were purchased from Vector Laboratories (Burlingame, CA). All antisera was tested by immunoadsorption and the dot blot technique according to criteria described elsewhere (32, 34) .
Immunolabeling of cryostat sections using peroxidase techniques
These techniques have been described in detail elsewhere (1, 2, 32) . In brief, the sections were incubated sequentially in an empirically derived optimal dilution of control serum or primary antibody raised in species "X" containing 1% goat serum in Tris-saline solution (0.9% NaCl in 0.1 m Tris, pH 7.4) for 18 h; a 1:50 dilution of anti-(species x) biotinylated IgG solution in 1% goat serum in TS for 30 min; and a 1:100 dilution of peroxidase-avidin complex for 30 min (avidin-biotin complex: ABC technique). Following these incubations, the bound peroxidase was visualized by reaction for 6 min in a solution containing 22 mg of 3,3Ј-diaminobenzidine (DAB) and 10 l of 30% H 2 O 2 in 100 ml of 0.1 m TS. After the DAB step, sections were dehydrated and mounted with Permount. Antibodies were used at the following dilutions: guinea pig antibovine IN-1:400; rabbit antihuman glucagon-1:12,000; rabbit antihuman somatostatin-1:8,000; rabbit antihuman pancreatic polypeptide-1:20,000; rabbit anti-PDX-1 at 1:500.
Double label immunohistochemistry using two peroxidase substrates
Sections were incubated first with antisera to PDX-1, and the bound antibody was visualized by DAB (brown precipitate), followed by incubation with antisera to a hormone, which was visualized with the blue reaction product of the Vector SG substrate (Vector Labs).
Analysis of double label slides
Slides processed for double immunohistochemical staining or for combined immunohistochemistry and autoradiography were examined with a Nikon (Garden City, NY) Microphot SA microscope equipped with Nomarski optics and using a 10ϫ ocular and an oil immersion 100ϫ objective. Depth of focus was calculated as previously described (3) . Briefly, the depth of focus was determined according to manufacture specifications and Klein and Furtak (35) as follows: With a depth of focus of approximately 0.4 m, only objects located at Ϯ0.4 m are within the same plane of focus. Therefore, structures from different cells can be easily distinguished because they are at different focal planes and cannot be focused simultaneously for photography. The small depth of focus of the objective used allowed us to clearly distinguish the presence (or absence) of staining in the nucleus and cytoplasm of individual cells. Only cells that contained immunostained nucleus and cytoplasm in the same plane of focus were scored as double labeled.
Determination of relative islet volume and ␤ cell mass
The relative islet volume was determined in sections immunostained for IN by the point sampling method (36) using a 300 point ocular grid at a total magnification of 400ϫ. The average number of ␤ cells per islet volume was calculated according to the formula: F ϭ h/n, in which h is the number of hits over ␤ cells and n is the number of points scored over islets (37) .
Semiquantitative assessment of insulinitis in islets of NOD mice
Pancreatic islets of NOD mice were scored as described in Ref. 38 . Sections stained for IN were examined using Nomarski interference optics, which allows the visualization of stained and unstained cells At least three mice per stage and six or more islets per animal were scored for islet infiltration and alteration of islet morphology. Islets with normal morphology, and no visible sign of infiltration were scored as 0. The score was 1 when the islets were surrounded by lymphocytes with little or no perturbation of islet structure, 2 when islets contained considerable lymphocyte infiltration and had significant alteration in islet structure, and 3 when islets were completely engulfed by lymphocytes and had only small clusters of endocrine cells.
Determination of labeling index (LI) using 3 H-thymidine
Mice received a single dose of the isotope (5 uCi/g, ip; NEN, specific activity approximately 80 uC/mmol). The animals were perfused with fixative solution 1 h or 24 h later, the pancreas was removed, and the sections processed for immunohistochemistry. After the DAB step, sections were dehydrated with ascending alcohols, cleared in xylene, rehydrated, air dried, and dipped in Ilford L-4 emulsion (Polysciences, Warrington, PA) at 50 C diluted 1:1 with distilled water. The autoradiographic preparations were air dried and exposed in light-proof boxes with dessicant for 4 C for 2-3 weeks. At the end of the exposure period, the slides were developed for 5 min in Kodak D-19 developer, rinsed in water, fixed with Ektaflo fixer for 10 min, washed in running water for 1 h, dehydrated, cleared, and mounted with a coverslip using Permount. 
Analysis of light microscopic autoradiography
Cells that were at the S phase of the cell cycle incorporated the isotope into the nucleus. The range of ␤ particles from tritium does not exceed 2 m (39), such that only 3 H-thymidine containing nuclei located within this distance from the emulsion will be decorated with silver grains, allowing the examination of cells that were located immediately below the emulsion. Examination of immunostained slides processed for autoradiography was performed using the same optical system and magnification described in the preceding section.
Processing of semithin sections
Semithin sections (1-m thick) were treated to remove the Epon (40) and were incubated at 4 C for 2-3 days with SOM, IN, or GLU antisera, respectively. Then, the sections were processed for visualization of the bound antibody by the ABC technique as described above. Antibodies were used at the following dilutions: guinea pig antibovine IN-1:50; rabbit antihuman glucagon-1:1000; rabbit antihuman somatostatin-1: 1000. Using this technique, we visualized IN ϩ and SOM ϩ cells, but not PP ϩ cells or PDX-1 ϩ cells because the procedure used to remove the epon abolished PP and PDX-1 immunoreactivity. In addition, we were unable to visualize IN in epon sections of NOD islets. Although this technique gave clear cellular localization of immunoreactive products, it precluded the survey of a large number of pancreatic islets. This was due to the small size of the islets present in SZ-treated mice, which prevented their visualization before embedding and sectioning.
Results
Reappearance of ␤ cells expressing PDX-1 and IN after SZ
One day after injection of SZ (1 day after SZ injection ϭ 1 day post SZ), most islet ␤ cells were destroyed in mice injected with 200 mg/kg SZ (200 SZ mice) ( Fig. 1 and Table 1 ). In addition to the ␤ cells, some GLU ϩ cells of 200 SZ mice were also necrotic (Fig. 1) . In contrast, there was no evidence of necrosis of Ѩ or PP cells. ture of cells that have responded to extremely high levels of glucose (27) . At 5 days post SZ, a substantial number of ␤ cells had reappeared ( Fig. 1 and Table 1 ). However, the average number of ␤ cells per islet volume was lower than in controls (Table 1 ). In addition, some islets were fibrotic, and the newly differentiated IN ϩ cells failed to fill the core of the islet. These studies strongly suggest that SZ eliminated almost all preexisting ␤ cells and that new IN ϩ cells gradually reappeared in the islets after injection of the drug.
␤ cells stressed by high glucose levels are degranulated and could appear IN Ϫ because their intracellular IN level is below the sensitivity of the immunohistochemical method. We therefore used PDX-1 as a nuclear ␤ cell marker that is independent of the secretory activity of the ␤ cell during hyperglycemia. In controls, PDX-1 was expressed by almost all ␤ cells ( Fig. 2A (Fig. 2D ). These observations indicated that the homeoprotein was expressed by a non-␤ cell population in the islet and confirmed the massive ␤ cell specific destruction caused by SZ. We also noted a transient increase in PDX-1 immunostaining in most of the exocrine cell nuclei at 1 day post SZ although these cells did not contain IN immunoreactivity (data not shown).
In 200 SZ mice, cells containing PDX-1 and IN reappeared within the islets by 5 days post SZ (Fig. 2E) . In contrast to noninjected littermates, only a subset (44.5% Ϯ 5.47, N ϭ 20) of the IN ϩ cells expressed the transcription factor at detectable levels (Fig. 2E) . A decrease in the percentage of ␤ cells expressing PDX-1 was also observed in 100 SZ mice at 5 days post SZ (data not shown). Similarly, almost 50% of IN ϩ cells present in severely affected islets lacked PDX-1 expression in NOD mice (data not shown). These observations indicated that the decrease in the percentage of ␤ cells expressing PDX-1 is not specific to SZ treatment. Because hyperglycemia dramatically decreases PDX-1 levels (42) 
cells during neogenesis
The observation that IN ϩ cells reappear after exposure to SZ raised the possibility that these cells were generated through the transient appearance of a population of IN ϩ / GLU ϩ /PDX-1 ϩ precursor cells, reminiscent of those seen in embryonic islet ontogeny. If this were the case, we expected to find an increase in the percentage of GLU ϩ /PDX-1 ϩ cells after SZ injection, suggesting that these stem cells were initiating IN synthesis. However, we found that the percentage of GLU ϩ cells that coexpressed PDX-1 (ϳ2%) did not change after exposure to SZ (Fig. 3) . In contrast, the percentage of SOM ϩ /PDX-1 ϩ cells increased dramatically 1 day after SZ injection ( Fig. 4) (Fig. 4) . The percentage of PP ϩ /PDX-1 ϩ cells was also transiently higher at 2 days post SZ than in controls (Fig. 3) although it did not reached the level previously determined in embryos (40.2% Ϯ 3.5; Ref 3). These observations suggest that in contrast to embryos, the IN ϩ cells are produced in adults from PDX-1 ϩ precursors expressing SOM (and possibly also PP).
To determine whether the increase in the percentage of SOM ϩ /PDX-1 ϩ cells was dependent upon the loss of most ␤ cells, we examined the islets of 100 SZ mice. In agreement with previous reports (17, 27, 43) , we found that a smaller fraction of ␤ cells is destroyed by 100 SZ than by 200 SZ treatment. The percentage of SOM ϩ /PDX-1 ϩ cells in pancreatic islets of 100 SZ mice also transiently increased at 2 days post SZ and subsequently decreased to control levels at 30 days post SZ (Fig. 4) . The magnitude of the increase in the percentage of SOM ϩ PDX-1 ϩ cells was similar between 100 SZ and 200 SZ mice (Fig. 4) . We conclude that the percentage of SOM ϩ /PDX-1 ϩ cells increases even after partial ␤ cell deletion.
SOM ϩ PDX-1 ϩ cells also appeared in islets of NOD mice
To ascertain whether the increase in the percentage of SOM ϩ /PDX-1 ϩ cells occurred in other cases of islet destruction, we analyzed islets from 1, 2, and 4-month-old NOD mice. All 1-month-old NOD mice examined were normo- glycemic, and their islets had no visible evidence of lymphocytic infiltration (score ϭ 0). Two-month-old NOD mice were also normoglycemic and had a combined islet cell destruction and insulinitis score of Յ 2 (criteria for score determination is described in Materials and Methods). At 4 months, one of the NOD mice analyzed had mild hyperglycemia (156 mg/dl), whereas the other three mice were severely hyperglycemic (blood glucose over 400 mg/dl). Pancreas of both normoglycemic and hyperglycemic 4-monthold mutant mice contained islets with different degrees of lymphocyte infiltration and endocrine cell number with a combined islet destruction score Յ 3. As expected, the number of affected islets was greater in hyperglycemic animals. Examination of sections of NOD pancreas processed for double immunostaining indicated that the percentage of SOM ϩ / PDX-1 ϩ cells was always higher in NOD mutant islets than in littermate controls (Figs. 5 and 6 ). However, there was a large variation in the percentage of SOM ϩ /PDX-1 ϩ cells, which ranged from 30% in islets with a normal morphology, to almost 80% in islets that were severely infiltrated. These findings suggest that the PDX-1 ϩ /SOM ϩ cells differentiate in islets of NOD mice and that the appearance of these cells occurs before the disruption of the structural organization of the islets.
␤ cell precursors coexpressed IN and SOM
To determine whether the SOM ϩ PDX-1 ϩ cells that appeared at 1 day post SZ were ␤ cell precursors that initiate IN expression, islets of 200 SZ mice were analyzed in consecutive 1 m epon sections for IN or SOM immunoreactivity. Because consecutive slides of this thickness contained sections of the same cells, we could estimate the percentage of cells expressing both hormones. Less than 1% of SOM ϩ cells coexpressed IN in controls (Fig. 7) . At 2 days post SZ (Fig. 8) , many SOM ϩ cells were present in the periphery of the islets while the core of the islets contained 1-5 IN ϩ cells. In contrast with 1 day post SZ, at 2 days post SZ, the core of the islet lacked clusters of IN ϩ granule-like substances, presumably because it was eliminated by macrophages that invaded the islet following SZ treatment (31) . Importantly, at 2 days post SZ, very few SOM ϩ cells (1.25% Ϯ 0.22) coexpressed IN (Fig. 8, A and B /GLU ϩ cells in SZ treated animals was similar to controls at both 2 and 5 days post SZ (data not shown).
Examination of consecutive epon sections of islets from 100 SZ mice at 2 and 5 days post SZ indicated that approx- (Fig. 9 ), a percentage similar to that found in islets of controls. Because of the small percentage of mixed cells, the IN ϩ and SOM ϩ cells in 100 SZ mice did not have an overlapping distribution (Fig.  9 ). These studies indicated that the two dosages of SZ tested induced a similar increase in the percentage of SOM Table 2 ). The increase in the rate of proliferation was transient, and the labeling index of SOM ϩ and PDX-1 ϩ cells decreased back to control levels by 5 days post SZ ( Table 2 ). The mitogenic effect of SZ-induced ␤ cell depletion was not specific for SOM ϩ and PDX-1 ϩ cells because the labeling index of GLU ϩ and PP ϩ cells of islets from 200 SZ mice also transiently increased at 2 days post SZ (Table 2) . At this stage, most islets did not contain IN ϩ cells, and the occasional ␤ cell present at that stage did not proliferate. In addition, the islet core contained dividing cells that did not express either PDX-1 or islet hormones (data not shown). At 5 days post SZ, the rate of proliferation of the newly differentiated ␤ cells was similar to controls (Table 2 ). 
Precursor cells in the pancreatic duct did not have a major role in ␤ cell neogenesis
It is generally believed that the pancreatic duct in adults contains islet precursor cells (1) . In agreement with this hypothesis, we found some PDX-1 ϩ cells in the pancreatic duct of SZ-treated and NOD mice. Some of these PDX-1 ϩ cells coexpressed IN, GLU, SOM, or PP (Fig. 10) , whereas other cells expressed GLU, SOM or PP, but not PDX-1 (not shown). We examined the mitotic index of these ductal cells in pancreata from 1, 2, and 5 days SZ mice. This analysis indicated that most of the PDX-1 ϩ and the hormone-containing cells present in the duct had not incorporated 3 H-thymidine (data not shown). In contrast, the acinar and connective tissues contained many cells that had incorporated the isotope (data not shown). The fact that the number of cells expressing PDX-1 ϩ and/or pancreatic hormones in the pancreatic duct of 1, 2, and 5 days post SZ was very low, and that most of these cells did not proliferate, indicates that the pancreatic duct was not a major source of islet stem cells in SZ-treated mice.
Discussion
Identification of adult ␤ precursor cells
During embryonic development, the endocrine and exocrine cells of the pancreas appear to develop from PDX-1 ϩ precursor cells (7, 8) . We have previously published evidence suggesting that all four islet cell types are generated from precursors that coexpress GLU, IN, and PDX-1 (3; Fig 11) . The aim of the present study was to ascertain whether similar or different PDX-1 ϩ stem cells exist in adult mouse pancreas and, if so, whether these precursors are responsible for the generation of new IN-producing cells in diabetic animals.
Cells expressing antigenic traits typical of endocrine precursor cells appeared in the pancreatic ducts of mice in all our diabetic models. These cells were surprisingly scarce and did not proliferate indicating that, in contrast to embryos, the duct is not a major source of islet precursor cells in the models of islet regeneration examined in this study. This observation argues against the generally held belief that the pancreatic duct of adults is the predominant source of ␤ cell precursors (23) (24) (25) . We also found that islet injury such as that induced by a ␤ cell toxin or autoimmune aggression led to the appearance of ␤ precursor cells in islets. The adult stem-like cells, however, did not have the immunohistochemical marker profile characteristic of embryonal ␤ stem cells (i.e. GLU 
/IN
ϩ cells that appeared at 5 days post SZ were generated by the few ␤ cells that survived the toxic injury and that these cells proliferated and initiated SOM expression. Two observations argue against this possibility. First, in agreement with previous reports (17), our 3 H-thymidine-labeling experiments indicate that the occasional ␤ cell that survived the SZ treatment did not proliferate during the first few days following the injection of the drug. In addition, we showed that a large number of SOM ϩ cells coexpressed IN at 5 days SZ. These observations are consistent with the proposition that the SOM 
ϩ cells but that these cells remained undetected in our studies because they had low levels of IN and/or they were rapidly eliminated by the immune system.
Source of PDX-
What is the source of the PDX-1 ϩ /SOM ϩ precursors that differentiate to IN ϩ cells? One source could be intra-islet hormone-null cells that do not express endocrine specific antigens. However, extensive histological examination of the islets has not yet revealed such a population of undifferentiated cells (44) . A second source of ␤ precursor cells could be the SOM ϩ /PDX-1 ϩ cells present in control (untreated) islets. Because 17% of the Ѩ cells of control islets expressed PDX-1, it seems reasonable to propose that these cells initiate IN expression and then generate monospecific IN ϩ cells, following the injection of SZ (Fig. 11 ). Finally, a third source of ␤ precursor cells could be the cells expressing SOM only. According to this possibility, monospecific SOM ϩ cells are induced by islet injury to reexpress PDX-1 and IN. In the 200 SZ model, some islets retained a near normal complement of SOM ϩ cells while other islets contained only a few SOM ϩ cells (Fig. 8) (3), whereas we show here that these cells produce IN ϩ cells during islet regeneration in adults. Thus, it is likely that the PDX-1 ϩ precursor cell type is committed to distinct developmental pathways in embryos and adults (Fig. 11 ). An alternate possibility is that IN/SOM ϩ stem cells are bipotential and produce monospecific IN and SOM cells during development and regeneration. It also remains to be determined whether the IN ϩ cells generated in SZ-treated islets from SOM ϩ /PDX-1 ϩ precursors contain all the properties characteristic of mature ␤ cells.
Possible signals for ␤ cell neogenesis in adult islets
Two precursor cell types appeared sequentially in adult islets during neogenesis. The first islet cell type to appear was the SOM ϩ /PDX-1 ϩ cells, which differentiated in islets of 100 SZ, 200 SZ, and NOD mice. Because the first two groups of mice were exposed to both high glucose leveIs and islet injury, it could be suggested that these two events cooperated in signaling the activation of PDX-1 expression by SOM ϩ cells. However, the finding that islets of normoglycemic young NOD mice contained large number of SOM ϩ /PDX-1 ϩ cells argues against a role of hyperglycemia in the differentiation of this precursor cell type. Taken together, these observations suggest that islet injury may be the principal event that initiated ␤ cell precursor differentiation. Our finding that structural normal islets of 1-month-old NOD mice contained a large percentage of SOM ϩ /PDX-1 ϩ cells appears to contradict this hypothesis. However, using an immunological rather than morphological approach, others identified infiltrating lymphocytes in islets of even younger NOD mice (46) , indicating that the cellular environment of apparently normal NOD islets is perturbed very soon after birth. The differentiation and proliferation of the population of IN ϩ stem cells may also be induced by the dramatic alteration in the three dimensional architecture produced during the elimination of the ␤ cell core in the islet. This hypothesis is particularly compelling because IN ϩ cell neogenesis occurred in islets of mice injected with 200 SZ but not in the less damaged islets of 100 SZ mice. There appears to be a tight relationship between islet structure and function (49) . Thus, alterations in intraislet cellular interactions may lead to profound changes in islet cell properties. These observations suggest that depletion of the normal complement of ␤ cells in islets of SZ treated and NOD mice may enable peripheral islet cell types to express novel phenotypic traits. Finally, the possibility that SZ itself promoted ␤ cell neogenesis has to be considered. As an alkylating agent, SZ induces DNA strand breaks and inhibits DNA repair (30) and may cause DNA recombinations that leads to the differentiation of islet precursor cells.
Although islets of 200 SZ mice contained a significant number of newly differentiated ␤ cells, the animals remained severely hyperglycemic at all stages, indicating that these cells fail to detect and/or respond efficiently to the increased blood glucose levels. It has been shown that excessive glucose stimulation permanently affects ␤ cell function (50 -52) . Conceivably, the new IN ϩ cells produced in SZ-treated mice are functionally defective because their differentiation occurs in a hyperglycemic environment. Because SZ impairs the response of mature ␤ cells to glucose (reviewed in Ref. 28) , it is also possible that the drug has a similar effect on ␤ stem cells. It would be of great interest to determine why these The proportion of labeled cells was determined in three animals per stage and in at least 12 randomly chosen islets. Total number of scored cells was over 500 per stage. SZ-treated mice were injected with the isotope, killed 1 hour later, and the pancreas processed for examination. The number of labeled cells in an islet was expressed as a percentage of the total number of that cell type in that islet. The average of these percentages is referred to as the labeling index (LI). ND, Not detected.
cells are dysfunctional and then to characterize conditions for appropriate maturation of precursor cells in adults to functionally normal glucose-sensitive, IN-producing ␤ cells. The answers to such questions could have important implications for the treatment of type I diabetes in humans. Guz et al., 1995) . During embryonic development, stem cells coexpressing the transcription factor PDX-1 and multiple hormones generate the mature monospecific islet cells. The derivation of all a cells from PDX-1 ϩ cells is uncertain because PDX-1 knockout mice contained a population of GLU ϩ cells (Offield et al., 1996) . In adults, PDX-1 is expressed by 90% of ␤ cells and by small subsets of Ѩ, ␣, and PP cells. Our present findings suggest that, in the SZ model, neoformed ␤ cells are generated by SOM ϩ PDX-1 ϩ precursor cells that initiate and IN expression eventually mature into monospecifc ␤ cells. This pathway of neogenesis is indicated with dashed arrows.
